Bio-Path Holdings Inc (BPTH)
2.635
+0.14
(+5.82%)
USD |
NASDAQ |
Apr 25, 16:00
2.54
-0.10
(-3.61%)
After-Hours: 05:31
Bio-Path Holdings Cash from Operations (TTM): -11.54M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.54M |
September 30, 2023 | -14.72M |
June 30, 2023 | -15.31M |
March 31, 2023 | -16.23M |
December 31, 2022 | -15.10M |
September 30, 2022 | -12.90M |
June 30, 2022 | -12.42M |
March 31, 2022 | -10.87M |
December 31, 2021 | -9.917M |
September 30, 2021 | -9.708M |
June 30, 2021 | -9.17M |
March 31, 2021 | -9.997M |
December 31, 2020 | -10.96M |
September 30, 2020 | -10.61M |
June 30, 2020 | -10.15M |
March 31, 2020 | -8.888M |
December 31, 2019 | -8.361M |
September 30, 2019 | -7.399M |
June 30, 2019 | -6.977M |
March 31, 2019 | -6.468M |
December 31, 2018 | -6.124M |
September 30, 2018 | -7.066M |
June 30, 2018 | -7.124M |
March 31, 2018 | -7.781M |
December 31, 2017 | -7.957M |
Date | Value |
---|---|
September 30, 2017 | -7.343M |
June 30, 2017 | -7.721M |
March 31, 2017 | -7.607M |
December 31, 2016 | -8.148M |
September 30, 2016 | -7.538M |
June 30, 2016 | -6.856M |
March 31, 2016 | -5.981M |
December 31, 2015 | -5.005M |
September 30, 2015 | -5.160M |
June 30, 2015 | -4.953M |
March 31, 2015 | -4.678M |
December 31, 2014 | -3.817M |
September 30, 2014 | -3.138M |
June 30, 2014 | -2.834M |
March 31, 2014 | -2.307M |
December 31, 2013 | -2.313M |
September 30, 2013 | -2.262M |
June 30, 2013 | -2.087M |
March 31, 2013 | -2.144M |
December 31, 2012 | -1.993M |
September 30, 2012 | -1.991M |
June 30, 2012 | -1.804M |
March 31, 2012 | -1.425M |
December 31, 2011 | -1.150M |
September 30, 2011 | -0.8787M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-16.23M
Minimum
Mar 2023
-6.977M
Maximum
Jun 2019
-11.12M
Average
-10.61M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
EyePoint Pharmaceuticals Inc | 1.875M |
INVO Bioscience Inc | -4.755M |
SINTX Technologies Inc | -14.12M |
Aileron Therapeutics Inc | -19.81M |
NovaBay Pharmaceuticals Inc | -4.131M |